Business
Abbott's FreeStyle Libre 3 Plus Now Covered Across Canada
Abbott's (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus* sensor, is now publicly funded in every province across Canadavi, in federal plans like Non-Insured Health Benefits (NIHB)vi and by a majority of employer-sponsored workplace benefits programs.i Coverage means more Canadians living with diabetes can experience the ease of the world's smallest glucose sensor.iv,v
About this update from Abbott Laboratories
[{"type":"list","items":[{"val":[{"type":"text","content":"Coverage means more Canadians with diabetes can access Abbott's sensor-based glucose technology, giving them actionable insights to manage their condition confidently,i","length":172,"tagName":"p"}]},{"val":[{"type":"text","content":"Abbott's latest innovation, the FreeStyle Libre 3 Plus* sensor, is easy to apply, ii easy to useiii and features the world's smallest glucose sensor, iv,v providing users with accurate and consistent glucose readings for up to 15 days.i,v","length":256,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":428,"olType":false},{"type":"text","content":"MISSISSAUGA, ON, Jan. 7, 2026 /PRNewswire/ -- Abbott's (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus* sensor, is now publicly funded in every province across Canadavi, in federal plans like Non-Insured Health Benefits (NIHB)vi and by a majority of employer-sponsored workplace benefits programs.i Coverage means more Canadians living with diabetes can experience the ease of the world's smallest glucose sensor.iv,v","length":461,"tagName":"p"},{"type":"text","content":"The Libre 3 Plus sensor delivers accurate and consistentv readings for up to 15 daysv and continuously measures a person's glucose levels to help them understand how food, medication, and exercise can affect their glucose.i","length":232,"tagName":"p"},{"type":"text","content":""Sensor-based glucose monitoring has transformed diabetes care," said Akshay Jain, M.D., a nationally recognized endocrinologist based in Surrey, British Columbia. "These intuitive tools, like the Libre 3 Plus, empower people living with diabetes to take control of their condition. This technology should be standard of care in Canada to ensure broad access and better health outcomes."","length":407,"tagName":"p"},{"type":"text","content":"Provincial and NIHB Coverage Coverage for the Libre 3 Plus* sensor is available to people living with diabetes in the following provinces who meet each province's eligibility criteriavi:","length":191,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Alberta","length":7,"tagName":"p"}]},{"val":[{"type":"text","content":"British Columbia","length":16,"tagName":"p"}]},{"val":[{"type":"text","content":"Manitoba","length":8,"t...